This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 14 Apr 2017  |  Global

    Robotics in Drug Discovery

    The introduction of automation and robotics into the drug discovery process has greatly enhanced the ability to explore and identify new drug candidates. Numerous chemical compounds can be manufactured and analyzed in a matter of a couple of weeks. Robotics can run tests on thousands of these compounds on biological samples for potential therapeuti...

    $950.00
  2. This Genetic Technology TOE depicts the current landscape across life sciences sector. 3D tissue microenvironment tests, protein-based drugs manufacturing, skin testing, cosmetics developments, and crowdsourcing for clinical trials are profiled. The corresponding industry interactions are also depicted. The Genetic Technology TechVision Opportunit...

    $250.00
  3. This Genetic Technology TOE profiles recent trends across biopharmaceutical technologies. The corresponding clinical trials are also depicted along with industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive fie...

    $250.00
  4. 31 Mar 2017  |  Global

    Recent FDA-approved Therapeutics

    This Genetic Technology TOE profiles therapeutics that have been recently approved by FDA. The corresponding clinical trials scenario is also depicted along with industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the exp...

    $250.00
  5. 29 Mar 2017  |  Europe

    Biosimilars Market, Europe, Forecast to 2025

    A Growing Number of Incentive Policies to Propel Growth in the Next 5–7 Years, with Oncology as the Fastest Adopter

    Patent expiration and increased use of traditional generic drugs are leading to a shift of focus in the pharmaceutical industry toward investment in specialty drugs and high growth areas such as biosimilars. Expensive biopharmaceuticals are largely used for life-saving disorders such as cancer and diabetes, the incidence of which is increasing with...

    $4,950.00
  6. 24 Mar 2017  |  Global

    Innovations in Medical Imaging

    The latest issue of Medical and Diagnostic Imaging TOE profiles innovations in medical imaging. Some of the profiles covered include optical biopsy technique for screening prostate cancer, low dose 3D dental imaging, angiography for intraoperative guidance, a non-invasive/non-ionizing imaging solution, elastography tool for assessment of liver heal...

    $950.00
  7. This Genetic Technology TOE depicts trends across genetic technologies. The corresponding clinical trial analysis for next-generation cancer immunotherapies is depicted, along with the industry interactions. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunitie...

    $250.00
  8. 23 Mar 2017  |  Asia Pacific

    APAC Molecular Diagnostics Market, Forecast to 2021

    Pharmerging Economies with Rising Healthcare Demands will Accentuate Growth

    The molecular diagnostics (MDx) market in APAC is witnessing rapid growth due to two main factors: the high adoption of MDx tests for infectious diseases applications in emerging countries, and the advent of innovative diagnostic solutions in cancer and NGS based solutions that are gaining pace in Asia. Multinational companies have not only identif...

    $4,950.00
  9. 17 Mar 2017  |  Global

    Innovations in Biologic Therapeutics

    This Genetic Technology TOE depicts trends across biologic therapeutics. With every therapy that is being discovered, there are subsequent discoveries made on the ideal candidates for these therapies. Unfortunately, due to the genetic and cellular variability present in diseases such as cancer, certain therapies are more suitable for a specific st...

    $250.00
  10. 14 Mar 2017  |  North America

    Game-changing Strategies of Leading US Pharma Companies

    Focus on Beyond the Pill Services, Process Automation, and Patient Engagement across the Value Chain to Drive Growth

    The research service primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing. The study provides key insights into the transforming pharmaceutical value chain, with the adoption of technology and shift towards digitalization of key processes ac...

    $1,500.00